Is progesterone effective for treating hot flashes in menopausal women, and should it be used alone or only as part of combined estrogen‑progesterone therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Progesterone for Hot Flashes in Menopausal Women

Progesterone alone is effective for treating hot flashes in menopausal women who cannot tolerate estrogen therapy, but estrogen-based therapy remains the first-line treatment for vasomotor symptoms. For women with a uterus taking estrogen, progesterone is mandatory to prevent endometrial hyperplasia and cancer, not optional 1.

Treatment Algorithm Based on Uterine Status

Women WITHOUT a Uterus

  • Use estrogen alone for hot flashes—progesterone adds no benefit and only increases side effects
  • Estrogen reduces hot flash frequency by approximately 75% 2
  • No need for progesterone since there's no endometrium to protect

Women WITH a Uterus

If tolerating estrogen:

  • Combined estrogen-progesterone therapy is required 1
  • Progesterone dose: 200 mg oral micronized progesterone at bedtime for 12 continuous days per 28-day cycle 3
  • This combination prevents endometrial hyperplasia (6% incidence vs 64% with estrogen alone) 3
  • The progesterone component is for endometrial protection, not hot flash treatment

If estrogen is contraindicated or not tolerated:

  • Progesterone monotherapy is a reasonable alternative 1
  • Dose: 300-400 mg oral micronized progesterone at bedtime 4
  • Reduces hot flashes by approximately 55-58% (vs 23.5% placebo) 5, 4
  • Less effective than estrogen (75% reduction) but superior to placebo 2

Evidence Quality and Nuances

The strongest evidence comes from the 2015 Endocrine Society Clinical Practice Guideline 1, which explicitly states: "For those who do not tolerate ET, progestogens can relieve VMS. In RCTs, oral synthetic progestogens and micronized progesterone were effective."

The pivotal RCT by Prior et al. (2012) 4 demonstrated that 300 mg oral micronized progesterone reduced hot flash scores significantly more than placebo in 133 healthy postmenopausal women over 12 weeks. A systematic review 5 confirmed these findings but noted heterogeneity in formulations and doses across studies.

Critical distinction: Depot medroxyprogesterone acetate (MPA) injections show even higher efficacy (79-90% reduction) 6, 7, but this is a different formulation than oral micronized progesterone.

Important Caveats

  • Take progesterone at bedtime due to drowsiness, dizziness, and potential sedation 3
  • Contains peanut oil—contraindicated in peanut allergy 3
  • Side effects include headache (31%), breast tenderness (27%), dizziness (15%), and vaginal bleeding 3
  • Discontinuation rates due to adverse events: 6-21% 5
  • Avoid in breast cancer patients—effect on recurrence is unclear 1

Practical Prescribing

For progesterone monotherapy:

  • Start with 300 mg oral micronized progesterone at bedtime 4
  • Can increase to 400 mg if inadequate response 5
  • Take with water while standing to prevent dysphagia 3
  • Expect 55-60% reduction in hot flashes within 12 weeks 5, 4
  • Monitor for excessive sedation, especially in first few weeks

Use only FDA-approved formulations—avoid custom-compounded progesterone due to lack of quality control and unproven endometrial protection 1.

When Progesterone Alone Is NOT Appropriate

  • Women without a uterus (use estrogen alone instead)
  • As first-line therapy when estrogen is tolerated (estrogen is more effective)
  • For prevention of cardiovascular disease (not indicated) 2
  • In women with active breast cancer (limited circumstances only) 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.